1. Home
  2. Labeler Index
  3. Abraxis Bioscience, Llc
  4. 68817-134
  5. NDC Package Code: 68817-134-50 Abraxane

NDC Package 68817-134-50 Abraxane

Paclitaxel Injection, Powder, Lyophilized, For Suspension Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68817-134-50
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE
Product Code:
68817-134
Proprietary Name:
Abraxane
Non-Proprietary Name:
Paclitaxel
Substance Name:
Paclitaxel
Usage Information:
This medication is used to treat certain cancers (including breast, lung, and pancreatic cancer). Paclitaxel belongs to a class of drugs known as chemotherapy drugs. It works by slowing or stopping the growth of cancer cells.
11-Digit NDC Billing Format:
68817013450
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 583214 - PACLitaxel 100 MG Injection
  • RxCUI: 583214 - paclitaxel 100 MG Injection
  • RxCUI: 583218 - Abraxane 100 MG Injection
  • RxCUI: 583218 - paclitaxel 100 MG Injection [Abraxane]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Abraxis Bioscience, Llc
    Dosage Form:
    Injection, Powder, Lyophilized, For Suspension - A liquid preparation, intended for parenteral use that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • PACLITAXEL 100 mg/20mL
    • Pharmacologic Class(es):
  • Microtubule Inhibition - [PE] (Physiologic Effect)
  • Microtubule Inhibitor - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA021660
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-10-2005
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 68817-134-50 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    68817013450J9264Paclitaxel protein bound1 MG11100100

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68817-134-50?

    The NDC Packaged Code 68817-134-50 is assigned to a package of 1 vial, single-use in 1 carton / 20 ml in 1 vial, single-use of Abraxane, a human prescription drug labeled by Abraxis Bioscience, Llc. The product's dosage form is injection, powder, lyophilized, for suspension and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 68817-134 included in the NDC Directory?

    Yes, Abraxane with product code 68817-134 is active and included in the NDC Directory. The product was first marketed by Abraxis Bioscience, Llc on February 10, 2005 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 68817-134-50?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 68817-134-50?

    The 11-digit format is 68817013450. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268817-134-505-4-268817-0134-50